Clinical and regulatory intelligence for Cardiovascular Disease with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Assets: 2

Relevant assets

Continuation →

Nutritional →

Relevant companies

No related entities indexed yet.

Recent signals(2)

ClinicalJuly 5, 2026

Continuation of nuMoM2b Heart Health Study to Address CVD in Women

The nuMoM2b Heart Health Study continues to follow a diverse cohort of women to explore the link between adverse pregnancy outcomes and cardiovascular disease.

ClinicalJune 24, 2026

Nutritional Screening Study Aims to Link Nutritional Status to Surgical Outcomes

The study evaluates the relationship between nutritional status and clinical outcomes in heart surgery patients.

Upcoming catalysts

No catalysts indexed for this entity yet.

Therapeutic areas

Cardiovascular Disease →

Nutritional Assessment →

Observational Study →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.